← Back to Search

Sensory Substitution Technology

BrainPort V200 Device for Blindness

N/A
Waitlist Available
Led By Ellen Mitchell, MD
Research Sponsored by Ellen Mitchell
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Between the age of 4 and 17.
Blind (documented visual acuity of light perception or worse) in both eyes from an eye care provider.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 visits over the course of approximately 2 weeks
Awards & highlights

Study Summary

This trial will test a non-surgical visual prosthetic on children who are blind to see if it can help them detect light, movement, and shapes.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 visits over the course of approximately 2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 visits over the course of approximately 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Evaluate BrainPort Device

Trial Design

2Treatment groups
Experimental Treatment
Group I: Sighted ChildrenExperimental Treatment1 Intervention
Children between the ages of 4 and 17 who are sighted in both eyes.
Group II: Blind ChildrenExperimental Treatment1 Intervention
Children between the ages of 4 and 17 who are blind (documented visual acuity of light perception or worse) in both eyes from an eye care provider.

Find a Location

Who is running the clinical trial?

Ellen MitchellLead Sponsor
Ellen Mitchell, MDPrincipal InvestigatorAssistant Professor of Ophthalmology

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Mar 2025